is tirzepatide a glp-1 drug Use of the dual GIP/GLP-1 (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort Tirzepatide vs Semaglutide | Understanding

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

Supports overall daily wellness

Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.

Common versions include tirzapetide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy/Rybelsus) and are available orally or subcutaneously (injections)

The plaintiffs allege that drugmaker Novo Nordisk didn't warn them about the risks of taking the medication

The popularity of GLP-1 weight loss drugs has exploded this past year, and so have the scams.